Patent · US Active

Chiral cis-imidazolines

US8513239B2 · kind B2 · utility

0Cited by

3References

36Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

David Joseph Bartkovitz · Nutley, US
Jianping Cai · West Caldwell, US
Xin-Jie Chu · Livingston, US
Hongju Li · Edison, US
Allen John Lovey · North Caldwell, US
Binh Thanh Vu · North Caldwell, US
Chunlin Zhao · Shanghai, CN

Key dates

Filing date	Oct 9, 2008
Grant date	Aug 20, 2013
Priority date	—
Expiry date	Apr 22, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/10
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

There are provided compounds of the formulaor the pharmaceutically acceptable salts thereof, wherein X, Y, Z, V1, V2, R1, R2, R3, R4 and R5 are herein described. These compounds are useful as anticancer agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.